Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
pharmaceutical investing Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial
Fibrocell Announces FDA Fast Track Designation of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Skyharbour Announces Appointment of Rob Chang to Board of Directors and Amanda Chow as Chief Financial Officer
Cartier Discovers New Porphyritic Intrusion-Related Gold System in Pontiac Sediments with 5.2 g/t Au over 5.0 m and 1.2 g/t Au over 25.5 m at Hope Target ; Large Scale Gold Mineralization Exploration Potential
